A critical role for choline kinase-alpha in the aggressiveness of bladder carcinomas.

Hernando E, Sarmentero-Estrada J, Koppie T, Belda-Iniesta C, Ramírez de Molina V, Cejas P, Ozu C, Le C, Sánchez JJ, González-Barón M, Koutcher J, Cordón-Cardó C, Bochner BH, Lacal JC, Ramírez de Molina A.

Oncogene. 2009 Jul 2;28(26):2425-35. Epub 2009 May 18.

PMID: 19448670 [PubMed - in process]

Related Articles

Optimal timing of radical cystectomy for patients with T1 bladder cancer.

Bochner BH.

Urol Oncol. 2009 May-Jun;27(3):329-31. Review.

PMID: 19414124 [PubMed - indexed for MEDLINE]

Related Articles

A role for neoadjuvant gemcitabine plus cisplatin in muscle-invasive urothelial carcinoma of the bladder: a retrospective experience.

Dash A, Pettus JA 4th, Herr HW, Bochner BH, Dalbagni G, Donat SM, Russo P, Boyle MG, Milowsky MI, Bajorin DF.

Cancer. 2008 Nov 1;113(9):2471-7.

PMID: 18823036 [PubMed - indexed for MEDLINE]

Related Articles

Defining Early Morbidity of Radical Cystectomy for Patients with Bladder Cancer Using a Standardized Reporting Methodology.

Shabsigh A, Korets R, Vora KC, Brook CM, Cronin AM, Savage C, Raj G, Bochner BH, Dalbagni G, Herr HW, Donat SM.

Eur Urol. 2008 Jul 18. [Epub ahead of print]

PMID: 18675501 [PubMed - as supplied by publisher]

Related Articles

Gene therapy in bladder cancer.

Bochner BH.

Curr Opin Urol. 2008 Sep;18(5):519-23. Review.

PMID: 18670278 [PubMed - indexed for MEDLINE]

Related Articles

Potential Impact of Postoperative Early Complications on the Timing of Adjuvant Chemotherapy in Patients Undergoing Radical Cystectomy: A High-Volume Tertiary Cancer Center Experience.

Donat SM, Shabsigh A, Savage C, Cronin AM, Bochner BH, Dalbagni G, Herr HW, Milowsky MI.

Eur Urol. 2008 Jul 14. [Epub ahead of print]

PMID: 18640770 [PubMed - as supplied by publisher]

Related Articles

Age-adjusted Charlson comorbidity score is associated with treatment decisions and clinical outcomes for patients undergoing radical cystectomy for bladder cancer.

Koppie TM, Serio AM, Vickers AJ, Vora K, Dalbagni G, Donat SM, Herr HW, Bochner BH.

Cancer. 2008 Jun;112(11):2384-92.

PMID: 18404699 [PubMed - indexed for MEDLINE]

Related Articles Free article in PMC | at journal site

Bladder cancer: can imaging change patient management?

Beyersdorff D, Zhang J, Schöder H, Bochner B, Hricak H.

Curr Opin Urol. 2008 Jan;18(1):98-104. Review.

PMID: 18090497 [PubMed - indexed for MEDLINE]

Related Articles

Extended pelvic resections for recurrent uterine and cervical cancer: out-of-the-box surgery.

Caceres A, Mourton SM, Bochner BH, Gerst SR, Liu L, Alektiar KM, Kardos SV, Barakat RR, Boland PJ, Chi DS.

Int J Gynecol Cancer. 2008 Sep-Oct;18(5):1139-44. Epub 2007 Dec 5.

PMID: 18053063 [PubMed - indexed for MEDLINE]

Related Articles

Longitudinal risk of upper tract recurrence following radical cystectomy for urothelial cancer and the potential implications for long-term surveillance.

Tran W, Serio AM, Raj GV, Dalbagni G, Vickers AJ, Bochner BH, Herr H, Donat SM.

J Urol. 2008 Jan;179(1):96-100. Epub 2007 Nov 13.

PMID: 17997449 [PubMed - indexed for MEDLINE]

Related Articles

Genomic and proteomic profiles reveal the association of gelsolin to TP53 status and bladder cancer progression.

Sanchez-Carbayo M, Socci ND, Richstone L, Corton M, Behrendt N, Wulkfuhle J, Bochner B, Petricoin E, Cordon-Cardo C.

Am J Pathol. 2007 Nov;171(5):1650-8.

PMID: 17982131 [PubMed - indexed for MEDLINE]

Related Articles Free article in PMC | at journal site

Risk assessment of prostatic pathology in patients undergoing radical cystoprostatectomy.

Pettus JA, Al-Ahmadie H, Barocas DA, Koppie TM, Herr H, Donat SM, Dalbagni G, Reuter VE, Olgac S, Bochner BH.

Eur Urol. 2008 Feb;53(2):370-5. Epub 2007 Jul 26.

PMID: 17689003 [PubMed - indexed for MEDLINE]

Related Articles

Highly efficient gene delivery for bladder cancers by intravesically administered replication-competent retroviral vectors.

Kikuchi E, Menendez S, Ozu C, Ohori M, Cordon-Cardo C, Logg CR, Kasahara N, Bochner BH.

Clin Cancer Res. 2007 Aug 1;13(15 Pt 1):4511-8.

PMID: 17671137 [PubMed - indexed for MEDLINE]

Related Articles Free article in PMC | at journal site

The use and abuse of data: nomograms and talking to patients about clinical medicine.

Lerner SP, Bochner B, Kibel AS.

Urol Oncol. 2007 Jul-Aug;25(4):333-7. Review.

PMID: 17628303 [PubMed - indexed for MEDLINE]

Related Articles

Prognostic significance of p27Kip1 expression in bladder cancer.

Rabbani F, Koppie TM, Charytonowicz E, Drobnjak M, Bochner BH, Cordon-Cardo C.

BJU Int. 2007 Aug;100(2):259-63. Epub 2007 Jun 6.

PMID: 17555476 [PubMed - indexed for MEDLINE]

Related Articles

A polymorphism in HDM2 (SNP309) associates with early onset in superficial tumors, TP53 mutations, and poor outcome in invasive bladder cancer.

Sanchez-Carbayo M, Socci ND, Kirchoff T, Erill N, Offit K, Bochner BH, Cordon-Cardo C.

Clin Cancer Res. 2007 Jun 1;13(11):3215-20.

PMID: 17545525 [PubMed - indexed for MEDLINE]

Related Articles Free article in PMC | at journal site

How prevalent is neobladder emptying failure, and how can it be treated?

Bochner BH.

Nat Clin Pract Urol. 2007 Jul;4(7):364-5. Epub 2007 May 15. No abstract available.

PMID: 17502889 [PubMed]

Related Articles

Urachal carcinoma: contemporary surgical outcomes.

Herr HW, Bochner BH, Sharp D, Dalbagni G, Reuter VE.

J Urol. 2007 Jul;178(1):74-8; discussion 78. Epub 2007 May 11.

PMID: 17499279 [PubMed - indexed for MEDLINE]

Related Articles

Radical cystectomy and lymphadenectomy for invasive bladder cancer: towards the evolution of an optimal surgical standard.

Raj GV, Bochner BH.

Semin Oncol. 2007 Apr;34(2):110-21.

PMID: 17382794 [PubMed - indexed for MEDLINE]

Related Articles

Treatment paradigm shift may improve survival of patients with high risk superficial bladder cancer.

Raj GV, Herr H, Serio AM, Donat SM, Bochner BH, Vickers AJ, Dalbagni G.

J Urol. 2007 Apr;177(4):1283-6; discussion 1286.

PMID: 17382713 [PubMed - indexed for MEDLINE]

Related Articles